EFFECTIVENESS OF THE LEVOSIMENDAN IN THE THERAPY OF DIASTOLIC DYSFUNCTION OF CARDIAC SURGERY.

Trial Profile

EFFECTIVENESS OF THE LEVOSIMENDAN IN THE THERAPY OF DIASTOLIC DYSFUNCTION OF CARDIAC SURGERY.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 17 May 2011

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Diastolic heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top